HuGE Literature Finder
Records
1
-
30
| The Cytochrome P450 2C19 Polymorphism is Associated with Major Adverse Cardiovascular Events Risk in Kazak Patients Undergoing Percutaneous Coronary Intervention and Receiving Clopidogrel. Endocrine, metabolic & immune disorders drug targets 2022 May . Wang Tingting, Feng Jie, Zhou Liying, Zhao Ting, Zhang Huilan, Shen Hao, Xu Li, Sun Li, Wu Jianhua, Li Hongjian, Yu Luh |
| Influence of Clinically Significant Genes on Antiplatelet Effect of Clopidogrel and Clinical Outcomes in Patients with Acute Coronary Syndrome and Atrial Fibrillation. Pharmacology 2022 Jan 1-11. Baturina Olga, Andreev Denis, Fedina Ludmila, Mirzaev Karin, Ivashchenko Dmitriy, Ryzhikova Kristina, Grishina Elena, Bochkov Pavel, Shevchenko Roman, Sychev Dmitr |
Genome-wide association analyses of symptom severity among clozapine-treated patients with schizophrenia spectrum disorders.
Translational psychiatry 2022 4 12 (1): 145. Okhuijsen-Pfeifer C, van der Horst M Z, Bousman C A, Lin B, van Eijk K R, Ripke S, Ayhan Y, Babaoglu M O, Bak M, Alink W, van Beek H, Beld E, Bouhuis A, Edlinger M, Erdogan I M, Ertu?rul A, Yoca G, Everall I P, Görlitz T, , Grootens K P, Gutwinski S, Hallikainen T, Jeger-Land E, de Koning M, Lähteenvuo M, Legge S E, Leucht S, Morgenroth C, Müderriso?lu A, Narang A, Pantelis C, Pardiñas A F, Oviedo-Salcedo T, Schneider-Thoma J, Schreiter S, Repo-Tiihonen E, Tuppurainen H, Veereschild M, Veerman S, de Vos M, Wagner E, Cohen D, Bogers J P A M, Walters J T R, Ya?c?o?lu A E Anil, Tiihonen J, Hasan A, Luykx J |
| Clinical Outcomes after Percutaneous Coronary Intervention Over Time on the Basis of CYP2C19 Polymorphisms. Journal of cardiovascular pharmacology 2021 Oct . Zhang Yang, Zhao Xiliang, Ye Yicong, Li Quan, Zeng Yo |
| Effects of CYP2C19*17 Genetic Polymorphisms on the Steady-State Concentration of Diazepam in Patients With Alcohol Withdrawal Syndrome. Hospital pharmacy 2021 Oct 56 (5): 592-596. Skryabin Valentin Yurievich, Zastrozhin Mikhail, Torrado Marco, Grishina Elena, Ryzhikova Kristina, Shipitsyn Valery, Galaktionova Tatiana, Sorokin Alexander, Bryun Evgeny, Sychev Dmit |
| Association between cytochrome P450 2C19 polymorphism and clinical outcomes in clopidogrel-treated Uygur population with acute coronary syndrome: a retrospective study. BMC cardiovascular disorders 2021 Aug 21 (1): 391. Yu Luhai, Wang Tingting, Bai Huidong, Zhu Weijiang, Li Yanju, Wu Jianhua, Liu Wenli, Sun Li, Yu Aiping, Li Hongji |
| Effects of Aging on Clinical Outcomes in Patients Receiving Genotype-Guided P2Y12 Inhibitor Selection after Percutaneous Coronary Intervention. Pharmacotherapy 2021 Jul . Wood Brian, Lee Craig R, Mulrenin Ian R, Gower Megan N, Rossi Joseph S, Weck Karen E, Stouffer George |
| The influence of acute coronary syndrome on levels of clopidogrel active metabolite and platelet inhibition in patients with and without CYP2C19*2(681 G>A), *3(636 G>A) and ABCB1(C3435C> T) gene polymorphisms. Postepy w kardiologii interwencyjnej = Advances in interventional cardiology 2021 Jun 17 (2): 179-186. Wójcik Tomasz, Karolko Bo?ena, Wi?niewski Jerzy, Mysiak Andrzej, ?ciborski Krzysztof, Onisk Grzegorz, Lebioda Arleta, Jonkisz Anna, Protasiewicz Marc |
| Clopidogrel in noncarriers of CYP2C19 loss-of-function alleles versus ticagrelor in elderly patients with acute coronary syndrome: A pre-specified sub analysis from the POPular Genetics and POPular Age trials CYP2C19 alleles in elderly patients. International journal of cardiology 2021 Apr . Claassens Daniel M F, Gimbel Marieke E, Bergmeijer Thomas O, Vos Gerrit J A, Hermanides Renicus S, van der Harst Pim, Barbato Emanuele, Morisco Carmine, Tjon Joe Gin Richard M, de Vrey Evelyn A, Heestermans Ton A C M, Jukema J Wouter, von Birgelen Clemens, Waalewijn Reinier A, Hofma Sjoerd H, den Hartog Frank R, Voskuil Michiel, Van't Hof Arnoud W J, Asselbergs Folkert W, Mosterd A, Herrman Jean-Paul R, Dewilde Willem, Mahmoodi Bakhtawar K, Deneer Vera H M, Ten Berg Jurriën |
| Role of serum amitriptyline concentration and CYP2C19 polymorphism in predicting the response to low-dose amitriptyline in irritable bowel syndrome. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2021 Mar . Zhou Wen-Cong, Jia Lin, Deng Qi, Wen Yu-Guan, Shang De-Wei, Ni Xiao-Jia, Huang Yao-Xing, Liu Yao, Zhao Han-Bing, Yang Meng, Dou Guo-Yu |
| Diabetes and CYP2C19 Polymorphism Synergistically Impair the Antiplatelet Activity of Clopidogrel Compared With Ticagrelor in Percutaneous Coronary Intervention-treated Acute Coronary Syndrome Patients. Journal of cardiovascular pharmacology 2020 Jul . Mohareb Mina W, AbdElghany Mohamed, Zaki Hala F, El-Abhar Hanan |
| Genomewide Association Study of Platelet Reactivity and Cardiovascular Response in Patients Treated With Clopidogrel: A Study by the International Clopidogrel Pharmacogenomics Consortium.
Clinical pharmacology and therapeutics 2020 May . Verma Shefali Setia, Bergmeijer Thomas O, Gong Li, Reny Jean-Luc, Lewis Joshua P, Mitchell Braxton D, Alexopoulos Dimitrios, Aradi Daniel, Altman Russ B, Bliden Kevin, Bradford Yuki, Campo Gianluca, Chang Kiyuk, Cleator John H, Déry Jean-Pierre, Dridi Nadia P, Fernandez-Cadenas Israel, Fontana Pierre, Gawaz Meinrad, Geisler Tobias, Gensini Gian Franco, Giusti Betti, Gurbel Paul A, Hochholzer Willibald, Holmvang Lene, Kim Eun-Young, Kim Ho-Sook, Marcucci Rossella, Montaner Joan, Backman Joshua D, Pakyz Ruth E, Roden Dan M, Schaeffeler Elke, Schwab Matthias, Shin Jae Gook, Siller-Matula Jolanta M, Ten Berg Jurriën M, Trenk Dietmar, Valgimigli Marco, Wallace John, Wen Ming-Shien, Kubo Michiaki, Lee Ming Ta Michael, Whaley Ryan, Winter Stefan, Klein Teri E, Shuldiner Alan R, Ritchie Marylyn D, |
| How do CYP2C19*2 and CYP2C19*17 genetic polymorphisms affect the efficacy and safety of diazepam in patients with alcohol withdrawal syndrome? Drug metabolism and personalized therapy 2020 Mar . Skryabin Valentin Yu, Zastrozhin Mikhail S, Torrado Marco V, Grishina Elena A, Ryzhikova Kristina A, Shipitsyn Valery V, Galaktionova Tatiana E, Sorokin Alexander S, Bryun Evgeny A, Sychev Dmitry |
| Pharmacodynamic study of prasugrel or clopidogrel in non-ST-elevation acute coronary syndrome with CYP2C19 genetic variants undergoing percutaneous coronary intervention (PRAISE-GENE trial). International journal of cardiology 2020 Jan . Jin Cai De, Kim Moo Hyun, Guo Long Zhe, Jin Enze, Shin Eun-Seok, Ann Soe Hee, Cho Young-Rak, Park Jong Sung, Kim Soo Jin, Lee Michael |
| CYP2C19 phenotype in South-East Asian Acute Coronary Syndrome patients and impact on major adverse cardiovascular events. Journal of clinical pharmacy and therapeutics 2019 Oct . Tan Doreen Su-Yin, Aw Jernice Wan Xin, Winther Michael, Goh Liuh Ling, Ong Hean Yee, Wee Eric, Liu Jianjun, Ho Han Ki |
| Interaction of CYP2C19 G681A polymorphism and omeprazole on clopidogrel responsiveness and impact in patients with acute coronary syndrome. Coronary artery disease 2019 Oct . Jirungda Sornsith, Pussadhamma Burabha, Komanasin Nantarat, Senthong Vichai, Leuangwatthananon W |
| Association of CYP2C19 Polymorphism with Clopidogrel Resistance in Patients with Acute Coronary Syndrome in China. Medical science monitor : international medical journal of experimental and clinical research 2019 Sep 25 7138-7148. Su Qiang, Li Jian, Tang Zhili, Yang Siyun, Xing Guoqiang, Liu Tao, Peng Ho |
| Effects of the rs2244613 polymorphism of the CES1 gene on the antiplatelet effect of the receptor P2Y12 blocker clopidogrel. Drug metabolism and personalized therapy 2019 Sep . Mirzaev Karin B, Osipova Darya V, Kitaeva Elena J, Shprakh Vladimir V, Abdullaev Sherzod P, Andreev Denis A, Mumladze Robert B, Sychev Dmitriy |
| Impact of Platelet Endothelial Aggregation Receptor-1 Genotypes on Platelet Reactivity and Early Cardiovascular Outcomes in Patients Undergoing Percutaneous Coronary Intervention and Treated With Aspirin and Clopidogrel. Circulation. Cardiovascular interventions 2019 May 12 (5): e007019. Xu Ke, Ye Sen, Zhang Shuhua, Yang Mingwen, Zhu Tiantian, Kong Deyu, Chen Jun, Xu Lei, Li Jimin, Zhu Hui, Wang Fei, Yang Lu, Zhang Jing, Fan Yuansheng, Ying Lianghong, Hu Xianqing, Zhang Xiaofeng, Chan Noel C, Li Chunji |
| Clopidogrel-associated genetic variants on inhibition of platelet activity and clinical outcome for acute coronary syndrome patients. Basic & clinical pharmacology & toxicology 2019 Jan 124 (1): 84-93. Li Xiaoye, Wang Zi, Wang Qibing, Xu Qing, Lv Qianzh |
| Both CYP2C19 and PON1 Q192R Genotypes Influence Platelet Response to Clopidogrel by Thrombelastography in Patients with Acute Coronary Syndrome. Cardiovascular therapeutics 2019 2019 3470145. Peng Wenxing, Shi Xiujin, Xu Xiaoyu, Lin Ya |
| Pharmacogenetic and clinical predictors of response to clopidogrel plus aspirin after acute coronary syndrome in Egyptians. Pharmacogenetics and genomics 2018 Sep 28 (9): 207-213. Fathy Shaimaa, Shahin Mohamed H, Langaee Taimour, Khalil Basma M, Saleh Ayman, Sabry Nagwa A, Schaalan Mona F, El Wakeel Lamiaa L, Cavallari Larisa |
| Genotype-Phenotype Association and Impact on Outcomes following Guided De-Escalation of Anti-Platelet Treatment in Acute Coronary Syndrome Patients: The TROPICAL-ACS Genotyping Substudy. Thrombosis and haemostasis 2018 Aug . Gross Lisa, Trenk Dietmar, Jacobshagen Claudius, Krieg Anne, Gawaz Meinrad, Massberg Steffen, Baylacher Monika, Aradi Daniel, Stimpfle Fabian, Hromek Julia, Vogelgesang Anja, Hadamitzky Martin, Sibbing Dirk, Geisler Tobi |
| Clustering of ABCB1 and CYP2C19 Genetic Variants Predicts Risk of Major Bleeding and Thrombotic Events in Elderly Patients with Acute Coronary Syndrome Receiving Dual Antiplatelet Therapy with Aspirin and Clopidogrel. Drugs & aging 2018 Jun . Galeazzi Roberta, Olivieri Fabiola, Spazzafumo Liana, Rose Giuseppina, Montesanto Alberto, Giovagnetti Simona, Cecchini Sara, Malatesta Gelsomina, Di Pillo Raffaele, Antonicelli Rober |
| Pharmacogenetic testing by polymorphic markers 681G>A and 636G>A CYP2C19 gene in patients with acute coronary syndrome and gastric ulcer in the Republic of Sakha (Yakutia). Drug metabolism and personalized therapy 2018 May . Fedorinov Denis S, Mirzaev Karin B, Ivashchenko Dmitriy V, Temirbulatov Ilyas I, Sychev Dmitriy A, Maksimova Nadezda R, Chertovskih Jana V, Popova Nyurguiana V, Tayurskaya Ksenia S, Rudykh Zoya |
| Genome-wide and candidate gene approaches of clopidogrel efficacy using pharmacodynamic and clinical end points-Rationale and design of the International Clopidogrel Pharmacogenomics Consortium (ICPC). American heart journal 2018 Apr 198 152-159. Bergmeijer Thomas O, Reny Jean-Luc, Pakyz Ruth E, Gong Li, Lewis Joshua P, Kim Eun-Young, Aradi Daniel, Fernandez-Cadenas Israel, Horenstein Richard B, Lee Ming Ta Michael, Whaley Ryan M, Montaner Joan, Gensini Gian Franco, Cleator John H, Chang Kiyuk, Holmvang Lene, Hochholzer Willibald, Roden Dan M, Winter Stefan, Altman Russ B, Alexopoulos Dimitrios, Kim Ho-Sook, Déry Jean-Pierre, Gawaz Meinrad, Bliden Kevin, Valgimigli Marco, Marcucci Rossella, Campo Gianluca, Schaeffeler Elke, Dridi Nadia P, Wen Ming-Shien, Shin Jae Gook, Simon Tabassome, Fontana Pierre, Giusti Betti, Geisler Tobias, Kubo Michiaki, Trenk Dietmar, Siller-Matula Jolanta M, Ten Berg Jurriën M, Gurbel Paul A, Hulot Jean-Sebastien, Mitchell Braxton D, Schwab Matthias, Ritchie Marylyn DeRiggi, Klein Teri E, Shuldiner Alan R, |
| Body Mass Index and Plasma P-Selectin before Coronary Stenting Predict High Residual Platelet Reactivity at 6 Months on Dual Antiplatelet Therapy. Cardiology 2018 Jan 139 (2): 132-136. Golukhova Elena Z, Grigoryan Marina V, Ryabinina Mariya N, Bulaeva Naida I, Serebruany Victor |
| Genetic mutations in PEAR1 associated with cardiovascular outcomes in Chinese patients with acute coronary syndrome. Thrombosis research 2018 03 163 77-82. Nie Xiao-Yan, Li Jun-Lei, Qin Si-Bei, Fu Yu, Liang Guang-Kai, Shi Lu-Wen, Shao Hong, Liu Jian, Lu Y |
| The role of pharmacogenetics of cytochrome P450s in phenytoin-induced DRESS syndrome. Central-European journal of immunology 2018 43 (2): 220-221. Ya?ar Üm |
| [Correlation between CYP2C19 Gene Polymorphism with Clopidogrel Resistance and Distribution of Chinese Medicine Syndrome in 229 Acute Coronary Syndrome Patients]. Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine 2017 Mar 37 (3): 291-296. Shen Zhi-Jie, Chen Xi-Ao-Kang, Wang Ying-Jie, Guo Wei, Chen Tie-Jun, Wang Xiao-Lo |
- Page last reviewed:Oct 1, 2021
- Page last updated:Jun 22, 2022
- Content source: